BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Guo C, Wu J. Therapeutic potential of PPARγ natural agonists in liver diseases. J Cell Mol Med 2020;24:2736-48. [PMID: 32031298 DOI: 10.1111/jcmm.15028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Moreno E, Cavic M, Krivokuca A, Canela EI. The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment. Cancers (Basel) 2020;12:E3275. [PMID: 33167409 DOI: 10.3390/cancers12113275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Geng X, Liu H, Yuwen Q, Wang J, Zhang S, Zhang X, Sun J. Protective effects of zingerone on high cholesterol diet-induced atherosclerosis through lipid regulatory signaling pathway. Hum Exp Toxicol 2021;:9603271211006170. [PMID: 33845646 DOI: 10.1177/09603271211006170] [Reference Citation Analysis]
3 He Y, Tao W, Shang C, Qi C, Ji D, Lu W, Chen G. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway. Int J Exp Pathol 2021;102:157-62. [PMID: 33993564 DOI: 10.1111/iep.12396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Vallée A, Vallée JN, Le Blanche A, Lecarpentier Y. PPARγ Agonists: Emergent Therapy in Endometriosis. Pharmaceuticals (Basel) 2021;14:543. [PMID: 34204039 DOI: 10.3390/ph14060543] [Reference Citation Analysis]
5 Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [DOI: 10.3748/wjg.v28.i28.3535] [Reference Citation Analysis]
6 Qin S, He Z, Wu Y, Zeng C, Zheng Z, Zhang H, Lv C, Yuan Y, Wu H, Ye J, Liu Z, Shi M. Instant Dark Tea Alleviates Hyperlipidaemia in High-Fat Diet-Fed Rat: From Molecular Evidence to Redox Balance and Beyond. Front Nutr 2022;9:819980. [DOI: 10.3389/fnut.2022.819980] [Reference Citation Analysis]
7 Xia Y, Li J, Chen K, Feng J, Guo C. Bergenin Attenuates Hepatic Fibrosis by Regulating Autophagy Mediated by the PPAR-γ/TGF-β Pathway. PPAR Res 2020;2020:6694214. [PMID: 33488687 DOI: 10.1155/2020/6694214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Liu J, Yao Q, Xie X, Cui Q, Jiang T, Zhao Z, Du X, Lai B, Xiao L, Wang N. Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism. Nutrients 2022;14:1756. [DOI: 10.3390/nu14091756] [Reference Citation Analysis]
9 Han X, Wu Y, Yang Q, Cao G. Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis. Pharmacol Ther 2021;222:107791. [PMID: 33321113 DOI: 10.1016/j.pharmthera.2020.107791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
10 Wu L, Yu Q, Cheng P, Guo C. PPARγ Plays an Important Role in Acute Hepatic Ischemia-Reperfusion Injury via AMPK/mTOR Pathway. PPAR Res 2021;2021:6626295. [PMID: 34285690 DOI: 10.1155/2021/6626295] [Reference Citation Analysis]
11 Wu L, Li J, Feng J, Ji J, Yu Q, Li Y, Zheng Y, Dai W, Wu J, Guo C. Crosstalk between PPARs and gut microbiota in NAFLD. Biomed Pharmacother 2021;136:111255. [PMID: 33485064 DOI: 10.1016/j.biopha.2021.111255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Wu L, Guo C, Wu J. Therapeutic potential of PPARγ natural agonists in liver diseases. J Cell Mol Med 2020;24:2736-48. [PMID: 32031298 DOI: 10.1111/jcmm.15028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
13 Baghcheghi Y, Beheshti F, Hosseini M, Gowhari-Shabgah A, Ali-Hassanzadeh M, Hedayati-Moghadam M. Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress. Clin Exp Hypertens 2022;:1-9. [PMID: 35722928 DOI: 10.1080/10641963.2022.2079669] [Reference Citation Analysis]
14 Solhi R, Lotfinia M, Gramignoli R, Najimi M, Vosough M. Metabolic hallmarks of liver regeneration. Trends Endocrinol Metab 2021;32:731-45. [PMID: 34304970 DOI: 10.1016/j.tem.2021.06.002] [Reference Citation Analysis]
15 Li J, Guo C, Wu J. The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis. Drug Des Devel Ther 2021;15:2619-28. [PMID: 34168433 DOI: 10.2147/DDDT.S310163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sanjay, Sharma A, Lee HJ. Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders. Biomedicines 2021;9:1914. [PMID: 34944727 DOI: 10.3390/biomedicines9121914] [Reference Citation Analysis]
18 Liu K, Zhao F, Yan J, Xia Z, Jiang D, Ma P. Hispidulin: A promising flavonoid with diverse anti-cancer properties. Life Sci 2020;259:118395. [PMID: 32905830 DOI: 10.1016/j.lfs.2020.118395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Yarmohammadi F, Hayes AW, Karimi G. Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds. Cardiovasc Toxicol. [DOI: 10.1007/s12012-021-09715-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhai XR, Zou ZS, Wang JB, Xiao XH. Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics. Front Pharmacol 2021;12:738577. [PMID: 34539416 DOI: 10.3389/fphar.2021.738577] [Reference Citation Analysis]
21 Yu Q, Cheng P, Wu J, Guo C. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. J Cell Mol Med 2021;25:1645-60. [PMID: 33438347 DOI: 10.1111/jcmm.16267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lin X, Meng X, Song Z, Lin J. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry. Mol Cell Biochem 2022. [PMID: 35348980 DOI: 10.1007/s11010-022-04417-0] [Reference Citation Analysis]
23 Niu L, Geyer PE, Gupta R, Santos A, Meier F, Doll S, Wewer Albrechtsen NJ, Klein S, Ortiz C, Uschner FE, Schierwagen R, Trebicka J, Mann M. Dynamic human liver proteome atlas reveals functional insights into disease pathways. Mol Syst Biol 2022;18:e10947. [PMID: 35579278 DOI: 10.15252/msb.202210947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dang G, Wu W, Zhang H, Everaert N. A new paradigm for a new simple chemical: butyrate & immune regulation. Food Funct 2021. [PMID: 34752597 DOI: 10.1039/d1fo02116h] [Reference Citation Analysis]
25 Ni XX, Li XY, Wang Q, Hua J. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway. J Physiol Biochem 2021;77:35-45. [PMID: 33188625 DOI: 10.1007/s13105-020-00777-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Garg S, Khan SI, Malhotra RK, Sharma MK, Kumar M, Kaur P, Nag TC, RumaRay, Bhatia J, Arya DS. The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction. Arch Biochem Biophys 2020;694:108572. [PMID: 32926843 DOI: 10.1016/j.abb.2020.108572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zheng Y, Li Y, Feng J, Li J, Ji J, Wu L, Yu Q, Dai W, Wu J, Zhou Y, Guo C. Cellular based immunotherapy for primary liver cancer. J Exp Clin Cancer Res 2021;40:250. [PMID: 34372912 DOI: 10.1186/s13046-021-02030-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Zhu C, Xiao H, Jiang X, Tong R, Guan J. Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma. Front Genet 2022;12:819520. [DOI: 10.3389/fgene.2021.819520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Li X, Zheng L, Zhang B, Deng Z, Luo T. The Structure Basis of Phytochemicals as Metabolic Signals for Combating Obesity. Front Nutr 2022;9:913883. [DOI: 10.3389/fnut.2022.913883] [Reference Citation Analysis]